Multidrug resistance 1 (MDR1, p-glycoprotein (P-gp), ABCB1) was the first human ATP binding cassette (ABC) transporter whose cDNA was cloned and characterized based on its ability to confer a multidrug-resistance phenotype to cancer cells. 1) Multidrug resistance-associated protein 1 (MRP1, ABCC1) and multidrug resistance-associated protein 2 (MRP2, ABCC2) have been identified as multidrug-resistance genes and demonstrated to transport glutathione conjugates of many toxic compounds.
Comparison of Inducibility of Multidrug Resistance (MDR)1, Multidrug Resistance-Associated Protein (MRP)1, and MRP2 mRNAs by Prototypical Microsomal Enzyme Inducers in Primary Cultures of Human and Cynomolgus Monkey Hepatocytes
; published online September 8, 2008 This study investigated the changes in the mRNA levels of the ATP binding cassette (ABC) transporters multidrug resistance 1 (MDR1), multidrug resistance-associated protein 1 (MRP1), and multidrug resistance-associated protein 2 (MRP2) following exposure to the prototypical microsomal enzyme inducers rifampicin (Rif), dexamethasone (Dex), and omeprazole (Ome) in primary cultures of cryopreserved human and cynomolgus monkey hepatocytes. Analysis was performed by real-time reverse transcription-polymerase chain reaction using primers and TaqMan probes. First, the time course of the mRNA expression of these transporters in primary cultures of human and cynomolgus monkey hepatocytes was examined in detail. The ratio of MDR1 and MRP2 mRNA to b b-actin mRNA in both human and cynomolgus monkey hepatocytes remained constant from 48 to 72 h and from 24 to 72 h of culture, respectively. Second, the hepatocytes were exposed to the inducers and the changes in the levels of the transporter mRNAs were examined. Rif increased MDR1 and MRP1 mRNA levels in both human and cynomolgus monkey hepatocytes, while Ome slightly increased MDR1 and MRP1 mRNA levels in cynomolgus monkey hepatocytes. Rif and Ome increased MRP2 mRNA levels in both human and cynomolgus monkey hepatocytes. In contrast, Dex tended to decrease the mRNA levels of MDR1, MRP1, and MRP2 in both human and cynomolgus monkey hepatocytes. Cynomolgus monkey hepatocytes appeared to be more responsive than human hepatocytes to the inducers. These results indicate that primary cultures of cynomolgus monkey hepatocytes are as useful as primary cultures of human hepatocytes for evaluating the induction of MDR1, MRP1, and MRP2 mRNAs in preclinical studies. Isolation of Cynomolgus Monkey Hepatocytes Perfusion of the cynomolgus monkey liver was performed according to the Seglen method 13) with some modifications. 14, 15) The hepatocytes obtained were stored in liquid nitrogen until use.
Monolayer Culture of Human and Cynomolgus Monkey Hepatocytes
Monolayer cultures of the cryopreserved human and cynomolgus monkey hepatocytes were prepared according to the method of Nishimura et al. 11) with some modifications. 14, 15) Human cell suspensions with viability rates of 90 to 94 as assessed by trypan blue dye exclusion and cynomolgus monkey cell suspensions with viability rates of 80 to 92 as assessed by the same method were used for the experiments. The hepatocytes were used for experiments at 48 h after inoculation.
Exposure of Primary Cultures of Human and Cynomolgus Monkey Hepatocytes to the Inducers In the induction studies, Hepatocyte Culture Medium without hEGF, hydrocortisone, gentamycin, or amphotericin B was used. The hepatocytes were exposed to the inducers Rif, Dex, and Ome (2, 10, 50 mM each) for 24 h. All inducers were dissolved in dimethyl sulfoxide (DMSO) at a final vehicle concentration of 0.1% (v/v). Controls were also exposed to DMSO at the same final concentration. Total RNA was extracted from the hepatocytes using the QIAshredder TM and RNeasy ® Mini Kit. Oligonucleotides The pairs of forward and reverse primers and the TaqMan probes for human and cynomolgus monkeys used in the reverse transcription-polymerase chain reaction (RT-PCR) sequences were designed using Primer Express software (Applied Biosystems). Each primer and probe was homology-searched by an NCBI BLAST search to ensure that it was specific for the target mRNA transcript. The pairs of forward and reverse primers and the TaqMan probes used for RT-PCR analysis are listed in Table 2 . The other probes have been reported elsewhere. 11, 14, 16) The primers and TaqMan probes were synthesized by the Genosys Division of Sigma-Aldrich Japan K. K. (Ishikari, Japan). The TaqMan probes contained 6-carboxyfluorescein (FAM) at the 5Ј end and 6-carboxytetramethylrhodamine (TAMRA) at the 3Ј end and were designed to hybridize to sequences located between the PCR primers.
TaqMan RT-PCR Conditions The total RNA was diluted to about 4 mg/ml with 50-mg/ml yeast tRNA. The RT-PCR assay was performed in 50 ml of TaqMan One-Step RT-PCR Master Mix Reagents containing 300 nM forward primer, 900 nM reverse primer, 200 nM TaqMan probe, and about 20 ng of total RNA. The RT-PCR assay was performed using the ABI PRISM 7700 Sequence Detector system (Applied Biosystems) under the same conditions as in our previous studies. 14, 15) Statistical Analysis Data analyses were performed with the ABI PRISM sequence detection software. The relative expression of each mRNA was calculated as the DCt (the value obtained by subtracting the Ct value of b-actin mRNA from the Ct value of the target mRNA). The amount of target The positions of the primers and probes were counted from the position of the initiation codon.
mRNA relative to b-actin mRNA was thus expressed as 2
. Values are given as the ratio of the target mRNA to b-actin mRNA. The experiments involving the hepatocyte cultures shown in Fig. 1 
RESULTS AND DISCUSSION
The time courses of the expression of MDR1, MRP1, and MRP2 mRNAs in primary cultures of human and cynomolgus monkey hepatocytes are shown in Fig. 1 . In the present study, the mRNA expression of MDR1, MRP1, and MRP2 in primary cultures of five lots of cryopreserved human and cynomolgus monkey hepatocytes was measured, and the differences in mRNA expression levels between the human and cynomolgus monkey hepatocytes were determined. b-Actin mRNA has been confirmed to exhibit stable expression under the same experimental conditions, 14, 17) and it was therefore used as an endogenous control for the measurement of the target mRNAs in the present study. The ratio of MDR1 mRNA to b-actin mRNA in both human and cynomolgus monkey hepatocytes decreased during the first 24 h of culture and then remained constant from 48 to 72 h of culture. The ratio of MRP1 mRNA to b-actin mRNA in both human and cynomolgus monkey hepatocytes decreased during the first 24 h of culture and then increased from 24 to 72 h of culture. The ratio of MRP2 mRNA to b-actin mRNA in both human and cynomolgus monkey hepatocytes also decreased during the first 24 h of culture and then remained constant from 24 to 72 h of culture. The expression levels of both MDR1 mRNA and MRP2 mRNA, which are expressed mainly in the liver as well as in many other tissues in humans 18) and cynomolgus monkeys (Nishimura, M. unpublished observation), remained constant from 48 h in primary cultures of both human and cynomolgus monkey hepatocytes. However, the expression levels of MRP1 mRNA, which is expressed at low levels in the liver in humans 18) and cynomolgus monkeys (Nishimura M., unpublished observation), continued to increase at 48 h in primary cultures of both human and cynomolgus monkey hepatocytes, and we therefore decided to start induction studies after 48 h of culture.
The changes in MDR1 mRNA levels induced by exposure to Rif, Dex, and Ome in primary cultures of human and cynomolgus monkey hepatocytes are shown in Fig. 2 . In the present study, 0.1% DMSO was used to dissolve the inducers, and the hepatocytes were exposed to the inducers for 24 h. This is because we previously found that 0.1% DMSO has no effects on induction 19) and also confirmed that the induction of drug-metabolizing enzyme and transporter mRNAs could be evaluated after 24 h of exposure to the inducers. 11, 14, 20) MDR1 mRNA levels in primary cultures of human hepatocytes increased 1.3-fold following exposure to Rif (2 to 50 mM) as compared with controls at 0.1% DMSO and were unaffected or only slightly decreased following exposure to Ome. MDR1 mRNA levels in primary cultures of cynomolgus monkey hepatocytes increased 1.2-to 1.8-fold following exposure to Rif (2 to 50 mM) and increased 1.1-to 1.5-fold following exposure to Ome (2 to 50 mM) as compared with controls at 0.1% DMSO. MDR1 mRNA levels in primary cultures of human and cynomolgus monkey hepato- 
Fig. 2. Effects of Exposure to Drugs on MDR1 mRNA Expression in Primary Cultures of Human and Cynomolgus Monkey Hepatocytes
The hepatocytes were used for experiments at 48 h after inoculation. The hepatocytes were exposed to Rif, Dex, or Ome for 24 h. The concentrations of Rif, Dex, and Ome were 2, 10, and 50 mM each. Values are the ratios of the target mRNA to b-actin mRNA. Experiments (cultures of human and cynomolgus monkey hepatocytes) were performed in triplicate using five livers each. Values are meanϮS.D. for five humans or five cynomolgus monkeys. The dotted line is 1 (the value for controls without DMSO, which was assigned a value of 1). * pϽ0.05 and * * pϽ0.01 vs. controls at 0.1% DMSO.
cytes decreased 0.7-to 0.8-fold and 0.7-to 0.9-fold, respectively, following exposure to Dex (2 to 50 mM) as compared with controls at 0.1% DMSO. These findings indicate that MDR1 mRNA levels in both human and cynomolgus monkey hepatocytes are increased by exposure to Rif and that the effect of Rif in increasing MDR1 mRNA levels is greater in cynomolgus monkeys than in humans.
The changes in MRP1 and MRP2 mRNA levels following exposure to Rif, Dex, and Ome in primary cultures of human and cynomolgus monkey hepatocytes are shown in Fig. 3 . In primary cultures of both human and cynomolgus monkey hepatocytes, MRP1 mRNA levels were not affected or only slightly affected by exposure to the inducers at 2, 10, or 50 mM. MRP2 mRNA levels in primary cultures of human hepatocytes increased 1.2-to 1.4-fold following exposure to Rif (2 to 50 mM) and 1.1-to 1.3-fold following exposure to Ome (2 to 50 mM) as compared with controls at 0.1% DMSO. MRP2 mRNA levels in primary cultures of cynomolgus monkey hepatocytes increased 2.1-to 3.0-fold following exposure to Rif (2 to 50 mM) and 1.3-to 2.8-fold following exposure to Ome (2 to 50 mM) as compared with controls at 0.1% DMSO. These findings indicate that MRP2 mRNA levels in both human and cynomolgus monkey hepatocytes are increased by exposure to Rif and Ome and that the rate of change in MRP2 mRNA levels following exposure to these inducers is greater in cynomolgus monkeys than in humans.
The results shown in Fig. 2 indicate that MDR1 mRNA expression in cynomolgus monkey hepatocytes as well as in human hepatocytes is up-regulated by exposure to Rif. 12) On the other hand, Mdr1a/1b mRNA expression in rat hepatocytes has been reported to be unaffected following exposure to Rif. 12) Furthermore, the present results (Fig. 3) indicate that MRP2 mRNA expression in cynomolgus monkey hepatocytes is markedly up-regulated, whereas that in human hepatocytes is moderately up-regulated, by exposure to Rif and Ome. In contrast to human hepatocytes, MRP2 mRNA expression in rat hepatocytes is markedly up-regulated by exposure to Dex. 12, [21] [22] [23] [24] Therefore, the species differences observed in the present study and a previous study 12) indicate that the comparative study of the mRNA induction of transporters using primary cultures of cryopreserved human, cynomolgus monkey, and rat hepatocytes may be useful for evaluating candidate drugs in preclinical drug development.
Currently available methodologies are thought to be inefficient for evaluating the induction of transporters by drugs. The FDA's Draft Guidance for Industry 25) contains some information concerning the inhibitory effects of drugs on various transporters, while information concerning inducing effects is limited to MDR1 (p-glycoprotein) alone. To the best of our knowledge, the inducing effects of Rif 26, 27) and St. John's wort 28) on MDR1 have been studied in vivo but not in vitro. In the present study, we conducted a comparative evaluation of the inducibility of MDR1 mRNA following exposure to Rif in primary cultures of cryopreserved hepatocytes, and found that MDR1 mRNA was induced by Rif in both human and cynomolgus monkey hepatocytes. We therefore consider that induction studies of MDR1 mRNA in primary cultures of cynomolgus monkey hepatocytes should be a good tool for evaluating the drug-drug interactions of drugs that are transported by MDR1.
When fresh human or cynomolgus monkey hepatocytes are employed, the cells can only be used one time, making it difficult to compare the data obtained in different studies. On the other hand, cryopreserved primary hepatocytes from a single donor can be used in multiple studies conducted at different times, and the data obtained in these studies can be compared. Furthermore, the induction method using primary cultures of cryopreserved cynomolgus monkey hepatocytes can provide large numbers of hepatocytes at low cost as compared to fresh cynomolgus monkey hepatocytes or fresh or cryopreserved human hepatocytes. This in vitro method using cryopreserved cynomolgus monkey hepatocytes is therefore expected to be useful for studying the induction of drug-metabolizing enzymes and transporters by new candidate drugs.
In our previous studies using primary cultures of cryopreserved hepatocytes, we demonstrated that following pretreatment with Ome, Rif and Dex, the mRNA induction profiles of CYP1A2, 14) CYP3As, 14) SULT2A1, 15) and UGT1A1 15) were similar in cynomolgus monkey and human hepatocytes. In the present study as well, the mRNA induction profiles of MDR1 and MRP2 in hepatocytes exposed to the same inducers were found to be similar in these two species. The present results and previous findings indicate that primary cultures of cynomolgus monkey hepatocytes are as useful as primary cultures of human hepatocytes for evaluating the induction of drug-metabolizing enzymes and transporters by new candidate drugs in preclinical drug development. The hepatocytes were used for experiments at 48 h after inoculation. The hepatocytes were exposed to Rif, Dex, or Ome for 24 h. The concentrations of Rif, Dex, and Ome were 2, 10, and 50 mM each. Values are the ratios of the target mRNA to b-actin mRNA. Experiments (cultures of human and cynomolgus monkey hepatocytes) were performed in triplicate using five livers each. Values are meanϮS.D. for five humans or five cynomolgus monkeys. The dotted line is 1 (the value for controls without DMSO, which was assigned a value of 1). * pϽ0.05, * * pϽ0.01, and * * * pϽ0.001 vs. controls at 0.1% DMSO.
